0
0
7/7/23 at 6:40pm
Organization
Yahoo Entertainment
Author
Anjalee Khemlani
38 words
0
Comments
Biogen and Eisai's second attempt at a new class of Alzheimer's treatments faces pressure despite regulatory and CMS greenlight.
You are the first to view
https://finance.yahoo.com/news/new-alzheimers-drug-from-biogen-eisai-gets-government-approval-but-faces-long-road-ahead-184008572.html
Create an account
or login to join the discussion